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Cellular origins of adult human islet in vitro
dedifferentiation
Stephen C Hanley1,2, Ame´lie Pilotte3,4, Bernard Massie3,4,5 and Lawrence Rosenberg1,2
Cultured human islets can be dedifferentiated to duct-like structures composed mainly of cytokeratinþ and nestinþ cells.
Given that these structures possess the potential to redifferentiate into islet-like structures, we sought to elucidate their
specific cellular origins. Adenoviral vectors were engineered for b-, a-, d- or PP-cell-specific GFP expression. A double-
stranded system was designed whereby cultures were infected with two vectors: one expressed GFP behind the cumate-
inducible promoter sequence, and the other expressed the requisite transactivator behind the human insulin, glucagon,
somatostatin or pancreatic polypeptide promoter. This system labels hormoneþ cells in the islet in a cell-specific manner,
allowing these cells to be tracked during the course of transformation from islet to duct-like structure. Post-infection,
islets were cultured to induce dedifferentiation. Fluorescence microscopy demonstrated that a-, d- and PP-cells
contributed equally to the cytokeratinþ population, with minimal b-cell contribution, whereas the converse was true for
nestinþ cells. Complementary targeted cell ablation studies, using streptozotocin or similar adenoviral expression of the
Bax (Bcl2-associated X protein) toxigene, validated these findings and suggested a redundancy between a-, d- and
PP-cells with respect to cytokeratinþ cell derivation. These results call into question the traditional understanding of islet
cells as being terminally differentiated and provide support for the concept of adult islet morphogenetic plasticity.
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Pancreatic b-cell mass is tightly regulated,1–3 reflecting
the net effect of homeostatic mechanisms that include
proliferation, neogenesis and apoptosis.4
With respect to neogenesis, small clusters of b-cells in close
proximity to pancreatic ducts are taken as a surrogate mea-
sure,5,6 given that this is the mechanism by which islets form
during pancreatic organogenesis.7 Reports also suggest that
pancreatic acinar tissue may serve as a source of new islets,
either directly8 or through duct-like intermediates.9 Intra-
islet progenitors have also been implicated.10–13 In fact,
varying degrees of islet-like morphology and function have
been reported in cultures derived from non-endocrine pan-
creatic cell sources.14–16 Unfortunately, the lineage relation-
ships that exist between pancreatic cell types, and the extent
to which this plasticity contributes to pancreatic b-cell mass
dynamics, are highly controversial.17,18 For example, the
physiological relevance of islet neogenesis as a mechanism of
b-cell renewal or regeneration has been questioned by lineage
tracing studies in mice.19,20 Nonetheless, elucidation of these
cellular inter-relationships may be key to the development of
novel diabetes therapies.
Notwithstanding this controversy, several groups,21–25 in-
cluding our own,26 have reported that cultured adult human
islets dedifferentiate into proliferative precursor-type cells,
expressing either cytokeratins (CK) or nestin. These cells can
in turn be induced to redifferentiate into islet-like structures,
given the appropriate stimulus. Preliminary results of
ultrastructural,26 immunofluorescence22,25,26 and pulse–chase21
experiments suggest that these precursor-type cells are of
endocrine origin. To provide more conclusive evidence,
recent studies have used islets from mice marked using
in vivo lineage tracing techniques.27–30 Chase et al cultured
islets isolated from mice engineered to express GFP in cells
having had an active pancreatoduodenal homeobox gene-1
(Pdx1) promoter,28 indelibly marking cells of all pancreatic
lineages.31 After culture, few if any GFPþ precursor-type cells
were identified, consistent with a non-pancreatic origin.
However, minimal islet redifferentiation has been reported
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from cultured mouse islets,27–30 suggesting an innate differ-
ence between mouse and human islet-derived cells.2,32 In fact,
a most recent lineage tracing study indicated that human
b-cells were capable of in vitro dedifferentiation whereas
murine b-cells were not.33
The aim of this study was to establish the cellular origins of
human islet-derived precursor-type cells, using adenoviral
vectors to specifically label individual endocrine cell types.
Identifying the exact source of precursor-type cells is a
necessary prelude to the development of techniques for
scaling up this process.
MATERIALS AND METHODS
Adenoviral vectors were engineered for b-, a-, d- or PP-cell-
specific expression (Table 1). A double-stranded system was
designed whereby cultures were infected with two vectors:
one expressed the marker (GFP or Bax (Bcl2-associated
X protein)) behind the cumate-inducible promoter
sequence34,35 and the other expressed the requisite transac-
tivator behind the promoter sequence of interest. In this way,
even low promoter activity would be sufficient to induce
expression of the transactivator, in turn amplifying the
signal34 with minimal delay.36 Similar coinfection systems
have been used with some success in isolated islets.37,38
Comparison of this system to GFP expression controlled
directly by the insulin promoter confirmed signal
amplification (data not shown).
Cell Culture
The 293 cell line (ATCC, Manassas, VA, USA), the
293CR5GFP cell line that stably expresses GFP under the
control of the cumate-inducible promoter35 and the BMAdE1
cell line (Qbiogene, Irvine, CA, USA) were grown in DMEM
Table 1 Adenoviral vectors
Vector Adenovirus Target Effect
CMV-GFP Ad-CMV-cTA +Ad-CR5-GFP All cells GFP label
INS-GFP Ad-INS-cTA +Ad-CR5-GFP b-Cells GFP label
GCG-GFP Ad-GCG-cTA +Ad-CR5-GFP a-Cells GFP label
SST-GFP Ad-SST-cTA +Ad-CR5-GFP d-Cells GFP label
PP-GFP Ad-PP-cTA +Ad-CR5-GFP PP-cells GFP label
0-BAX Ad-CR5-Bax No cells Apoptosis
CMV-BAX Ad-CMV-cTA +Ad-CR5-Bax All cells Apoptosis
Ad-INS-cTA
INS/GCG/SST/PP-BAX +Ad-GCG-cTA +Ad-CR5-Bax Endocrine cells Apoptosis
+Ad-SST-cTA
+Ad-PP-cTA
INS-BAX Ad-INS-cTA +Ad-CR5-Bax b-Cells Apoptosis
Ad-GCG-cTA
GCG/SST/PP-BAX +Ad-SST-cTA +Ad-CR5-Bax a-, d-, PP-cells Apoptosis
+Ad-PP-cTA
GCG-BAX Ad-GCG-cTA +Ad-CR5-Bax a-Cells Apoptosis
Ad-INS-cTA
INS/SST/PP-BAX +Ad-SST-cTA +Ad-CR5-Bax b-, d-, PP-cells Apoptosis
+Ad-PP-cTA
SST-BAX Ad-SST-cTA +Ad-CR5-Bax d-Cells Apoptosis
Ad-INS-cTA
INS/GCG/PP-BAX +Ad-GCG-cTA +Ad-CR5-Bax b-, a-, PP-cells Apoptosis
+Ad-PP-cTA
PP-BAX Ad-PP-cTA +Ad-CR5-Bax PP-cells Apoptosis
Ad-INS-cTA
INS/GCG/SST-BAX +Ad-GCG-cTA +Ad-CR5-Bax b-, a-, d-cells Apoptosis
+Ad-SST-cTA
Human islet in vitro dedifferentiation
SC Hanley et al
762 Laboratory Investigation | Volume 88 July 2008 | www.laboratoryinvestigation.org
(Wisent, St-Bruno, QC, Canada) containing 5% serum and
2mM L-glutamine.
Plasmids
Plasmids containing cTA behind the promoter sequence of
interest (pAd-promoter-cTA) were constructed by replacing
the cytomegalovirus (CMV) promoter portion of the
pAdPS-CMV-cTA-DC-GFP plasmid35 with the promoter
sequence of interest (Table 2), amplified by PCR from
genomic DNA extracted from 293 cells using the DNeasy
tissue kit (Qiagen, Mississauga, ON, Canada).
Plasmid containing Bax controlled by the CR5 promoter
(pAd-CR5-Bax) was constructing by inserting the Bax coding
sequence (a generous gift from Dr B Fang, University of
Texas MD Anderson Cancer Center)46 in place of GFP in the
pAd-CR5-GFP vector.
Adenoviral Production
pAd-promoter-cTA plasmids were used to produce adeno-
viral vectors, using a positive selection method based on the
rescue of protease-, E1- and E3-deficient adenoviruses
(Qbiogene), as previously described.47,48 Homogeneously
green fluorescent plaques on 293CR5GFP were picked
and eluted.
Recombinant adenoviral vectors were amplified by con-
secutive passages in BMAdE1 cells, except for the last passage,
which was in 293A cells, as per standard procedures. Ade-
noviruses were purified by centrifugation on CsCl gradients
using standard procedures. Viral titer was determined by
plaque assay on 293CR5GFP cells, as described previously.49
The adenoviral vector expressing GFP under the control of
the cumate-inducible promoter (Ad-CR5-GFP) has been
described previously.35 The adenoviral vector expressing
Bax under the control of the cumate-inducible promoter
(Ad-CR5-Bax) was produced as described above.
Islet Isolation
Pancreata from adult human cadaveric organ donors were
obtained through the local organ procurement organization
(Table 3). Islets were isolated according to established
protocols.50 Free islets with diameters ranging from 75 to
400 mm, determined to be greater than 75% pure by real-time
staining with dithizone (Sigma, St Louis, MO, USA), a Zn2þ
chelator, were collected, washed and counted as islet
equivalents (IE¼ islet with a diameter of 150 mm).
Islet Infection
Islets were infected 2 days post-isolation, at a density of
2500 IE/ml and an MOI of 5000/IE for Ad-CR5-GFP or
Ad-CR5-Bax, and an MOI of 50 000/IE for Ad-promoter-
cTA. After 6 h, the medium was added to a density of 1000
IE/ml. Islets were further incubated for 4 days to allow
marker expression to develop before culturing to form
duct-like structures (DLS). Controls included mock
infection, infection with Ad-CR5-GFP or Ad-CR5-Bax alone
(MOI of 5000/IE), or in combination with Ad-CMV-cTA
(MOI of 50 000/IE).
Table 2 Promoter sequences
Gene Position Primers Reference
INS 717 to 170 50-TTTCTCGAGACAGGGGTGTGGGGACAG-30
50-GCTTTGATATCCCTGACGCAAAGGCCCTG-30
39,40
GCG 3660 to 2931 50-CGGAACTCGAGAAACAGAACACATAGGGGT-30
50-CTGAGATATCCTTCACTGTCCGCCAAAC-30
41,42
SST 1075 to +158 50-CCGCTCGAGGCTTCCTGACATAAAACTATGC-30
50-CTGGATATCGTCGAGGGAGTCTCCTTACC-30
43,44
PP 1740 to 766 50-GCGGCGGGCGGATATCGTGGGAAATTATAACAATAC-30
50-GGCGGAGATCTAGAGTAAATGGGCACTAGAAC-30
45
Table 3 Donor and isolation characteristics
Study isolations Isolations
2005–2007a
P
n 17 61
Age (years) 51.5±3.5 52.2±1.8 NS
Sex (% male) 47 58 NS
BMI (kg/m2) 29.4±1.0 27.4±0.6 NS
Cause of death (% traumatic) 38 27 NS
ICU duration (days) 2.8±0.5 2.5±0.3 NS
Glucose (mM) 9.5±0.7 9.1±0.4 NS
Amylase (U/l) 193±64 213±39 NS
Cold ischemia (h) 7.7±1.1 6.7±0.7 NS
Yield Z70% pure (IE)b 306 727±30 268 272 267±22 009 NS
a
Indicates all isolations performed during the calendar years 2005–2007.
b
Indicates the yield (in islet equivalents) of islets having a minimum purity of 70%.
Human islet in vitro dedifferentiation
SC Hanley et al
www.laboratoryinvestigation.org | Laboratory Investigation | Volume 88 July 2008 763
Streptozotocin Treatment
In select groups, islets were pretreated with 5mM
streptozotocin (STZ; Sigma), prepared in 0.1M citrate buffer
(pH 4.5), for 30min before embedding.
Islet Culture
Infected islets were washed in serum-free DMEM/F12
(Gibco, Burlington, ON, Canada) containing penicillin,
streptomycin, fungizone, 1mM dexamethasone, 10 ng/ml
EGF (Sigma), 24mU/ml insulin (Lilly, Toronto, ON, Canada)
and 200 ng/ml cholera toxin (Sigma) before embedding. Islets
were then embedded in type I rat tail collagen, as per pre-
vious reports,51 at a density of 2000 IE/25 cm2 and cultured
for 8 days in the above medium, with media changes every
other day. To remove tissue from collagen, samples were
incubated with 0.25mg/ml collagenase XI (Sigma) for 30min
at 371C. To disperse cultures into single cells, samples were
washed twice in HBSS before incubation in 0.05% trypsin-
EDTA (Invitrogen) for 10min at 371C. Samples were then
washed in serum-containing medium before fixing in 4%
phosphate-buffered formalin at 41C.
In selected groups, spontaneous islet redifferentiation was
assessed by switching DLS cultures to the above islet culture
medium, with 10% serum but without cholera toxin, for 4
days (redifferentiation medium). Islet redifferentiation was
also induced by adding 667 nM islet neogenesis-associated
protein (INGAP) peptide (Sheldon Biotech, Montre´al, QC,
Canada).26
Immunofluorescence
For immunofluorescence studies, samples of 4000 IE were
dispersed into single cells and then aliquots were applied to
microscopic slides by cytocentrifugation. Slides were then
processed for immunofluorescence as per standard proto-
cols.52 Antibodies used were rabbit a-insulin (Santa Cruz
Biotechnology, Santa Cruz, CA, USA), rabbit a-glucagon,
a-somatostatin and a-pancreatic polypeptide, mouse a-CK-
AE1/AE3 (Dako, Carpinteria, CA, USA) and mouse a-nestin
(Abcam, Cambridge, MA, USA) primary antibodies, along
with FITC- and rhodamine-linked a-rabbit and a-mouse
secondary antibodies (Abcam). To assess cell death, samples
were processed using a TUNEL kit (Roche). Images were
captured using a Zeiss Axioskop 40 microscope and Northern
Eclipse v6.0 (Empix Imaging, Mississauga, ON, Canada), and
at least 400 cells were counted per sample (528±27 cells).
Statistical Analysis
All experiments were performed using islets from a mini-
mum of three donors (the number of biological replicates is
indicated in the figures and tables) and experiments were
paired in that control and treatment groups from the same
donor were compared. Results are expressed as mean±s.e.m.
Statistical significance was determined by one-way ANOVA
with a post hoc Bonferroni’s test, or paired Student’s t-test,
when applicable. Differences were considered significant
when Po0.05.
RESULTS
Islet Purity and Composition
Immunofluorescence studies (Table 4) determined islet
samples to be 72.7±5.0% hormoneþ and 3.0±0.9% CKþ .
A total of 0.3±0.4% were hormoneþ /CKþ whereas
23.2±8.7% were hormone/CK and likely consisted of
acinar and dead cells. Preparations also contained 5.2±1.1%
nestinþ cells, although these cells were in fact nestinþ /
insulinþ . Cell frequencies (53:28:13:5 for b:a:d:PP) were in
keeping with previous reports for human islets.53
GFP Expression
Following adenoviral infection, islet samples were collected to
assess labeling efficiencies and specificities. Immuno-
fluorescence microscopy analysis determined that cell type-
specific vectors had highly reproducible labeling efficiencies
(Table 5 and Figure 1a). It is the reproducibility of these
labeling efficiencies and not the specific labeling efficiency
that allows subsequent analyses. Moreover, these vectors
Table 4 Cell frequencies
Marker Islet—day 0 (%) DLS—day 8 (%) P n
Insulin 38.9±2.5 2.4±0.9 o0.001 7
Glucagon 20.1±1.4 3.1±0.7 o0.001 7
Somatostatin 9.2±1.1 2.9±0.6 o0.001 7
Pancreatic polypeptide 4.0±0.5 2.9±0.5 0.056 7
Total endocrine 72.7±5.0 11.3±2.0 o0.001 7
Cytokeratin 3.0±0.9 40.3±3.7 o0.001 8
Nestin 5.2±1.1 17.6±2.4 o0.001 8
DLS, duct-like structures.
Table 5 Labeling efficiencies and specificities
Vector Efficiency (%)a Specificity (%)b n
INS-GFP 35.0±3.4 97.1±1.7 4
GCG-GFP 49.8±0.8 99.1±1.1 3
SST-GFP 46.3±3.2 100 4
PP-GFP 43.9±1.9 100 3
a
Indicates the fraction of hormone+ cells (for the promoter of interest) also
found to be GFP+, and indicates the cell type-specific labeling efficiency of the
individual vectors. General infection efficiency was 46.5±1.0%, as assessed
using a CMV-GFP infection (n¼ 3).
b
Indicates the fraction of GFP+ cells also found to be hormone+ (for the
promoter of interest), and indicates the cell type specificity of the individual
vectors.
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appear to be highly specific, as few promoter-driven GFPþ
cells were observed that did not also express the hormone of
interest (Table 5).
Duct-Like Structure Formation
Following collagen embedding and over 8 days of culture,
islets became cystic DLS, composed of one to several layers of
low cuboidal-type cells in thickness (Figure 1b). Previously,
we reported that DLS appeared to form through a combi-
nation of b-cell apoptosis and a-, d- and PP-cell trans-
differentiation. Furthermore, DLS express high levels of
epithelial and progenitor markers and low levels of endocrine
markers, and have the ability to redifferentiate into islet-like
structures given the appropriate stimulus.26 It is noteworthy
that cells that comprise the DLS appear to be similar to those
found in islet monolayers,21–25 both with respect to the
required culture conditions and the presence of
nestinþ /vimentinþ and CKþ /E-cadherinþ cells.26
To confirm that selective b-cell apoptosis was in fact
occurring during the process of DLS formation, we assessed
Figure 1 Embedded islets form DLS. (a) Fluorescence microscopy of islet cells, post-infection but pre-embedding, confirms the specificity and efficiency
of the GFP-expressing adenoviral vectors. (b) Isolated human islets are solid spherical structures comprised of hormoneþ cells. After collagen embedding
and culture, islets form DLS, cystic structures comprised of CKþ and nestinþ cells, as determined by inverted and immunofluorescence microscopy.
(c) Quantification of apoptotic cell death before embedding and during the course of DLS formation indicates that b-cells preferentially undergo
apoptosis during DLS formation. (d) Visual assessment of DLS formation after 8 days in culture confirms that adenoviral infection does not affect the ability
of islets to form DLS (n¼ 3; *Po0.05, zPo0.01, yPo0.001 vs day 0, bar¼ 100mm).
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apoptosis before embedding and at day 2 of culture (Figure 1c),
the point of maximal DLS formation.52 While little apoptosis
was observed in endocrine cells before embedding, DLS for-
mation was associated with a significant increase in apoptosis in
all endocrine cells. However, b-cell apoptosis was the most
prevalent, affecting nearly half of b-cells. Of note, non-endo-
crine cells also appeared to be affected by ongoing apoptosis.
We have previously reported that the process of DLS
formation is complete by 8 days of culture.52 Given the
apparent unidirectional differentiation occurring in this
model, as well as the objective of determining cellular origins,
we chose to analyze DLS cultures at this single time point
(Figure 2a). By immunofluorescence microscopy, we de-
termined that 40.3±3.7% of cells in DLS cultures were CKþ
and 17.6±2.4% were nestinþ . Only 11.3±2.0% of cells re-
tained hormone expression (Table 4), indicating that the
majority of cells either died or became CKþ or nestinþ .
Islet Cell Fate
To evaluate the fate of specific islet cell types, DLS cultures
were assessed by immunofluorescence microscopy to de-
termine the relative frequencies of GFPþ cells (Figure 2b and c).
Only a minority of GFPþ cells were also hormoneþ , in-
dicating that most GFP-labeled cells had ceased to express
hormone. GFP-labeled b-cells, however, were more likely
than other endocrine cells to retain hormone expression.
Moreover, in all samples assessed, no cells were found that
coexpressed promoter-driven GFP and any other islet hor-
mone. This suggests that no transdifferentiation from one
endocrine cell type to another was occurring in our model.
Adenoviral infection did not affect the transformation of
islets into DLS (Figure 1d).
With respect to CKþ cell formation, a dichotomy was
apparent between b-cells and a-, d- and PP-cells: 5.0±5.0%
of GFPþ b-cells acquired CK expression during DLS for-
mation, as compared to B75% of labeled a-, d- or PP-cells.
These results support our previous observations of CKþ /
glucagonþ and CKþ /somatostatinþ double immuno-
fluorescence, without any indication of a CKþ /insulinþ cell
population.26 The opposite was true with respect to nestin
expression: 84.2±5.1% of GFPþ b-cells became nestinþ , as
compared to only B4% of labeled a-, d- or PP-cells.
Few insulinþ /nestinþ cells are observed in freshly isolated
human islets,54 whereas we noted that islets cultured in sus-
pension for 1 week contained 5.2±1.1% nestinþ cells (Table 4),
most of which were also insulinþ . One explanation is that b-cell
dedifferentiation is initiated in islets even before embedding.55
DLS Cell Origins
To establish the contributions of individual endocrine cell
types to the subpopulations of the DLS, the frequencies of
GFPþ /CKþ and GFPþ /nestinþ cells were calculated relative
to the frequencies of CKþ and nestinþ cells (Table 6).
Accounting for labeling efficiencies, the overall contribu-
tion of b-cells to the CKþ cell population was minimal. The
contributions of a-, d- and PP-cells were nearly equal, with
each cell type providing approximately one-third of the final
CKþ cell population. Moreover, based on labeling effi-
ciencies, a-, d- and PP-cells appeared to be the main con-
tributors to the population of CKþ cells.
Conversely, an adjusted 74.4±0.5% of nestinþ cells were
of b-cell origin, with a minimal contribution from a-, d- and
PP-cells. It should be noted, however, that at 6.1±1.1%, the
PP-cell contribution, although minor compared to that of
b-cells, was nevertheless more than that of either a- or d-cells.
Additionally, a significant proportion of nestinþ cells could
not be accounted for by the dedifferentiating b-cell popula-
tion, suggesting a possible non-endocrine origin for some of
these cells.
Bax Targeting
To confirm the contribution of specific endocrine cell types
to DLS formation, islet cell types were targeted for apoptosis
by promoter-mediated Bax expression. Post-infection, sam-
ples were assessed for specificity of cell death induction
(Figure 3). Cell type-specific Bax expression induced an
B75% reduction in targeted cell types, without adversely
affecting the frequency of other cell types, although overall
cell numbers and frequencies were affected accordingly.
Bax-infected cultures were evaluated for DLS formation
(Figure 4a) and for the frequencies of the constituent DLS
cell subtypes (Figure 4b). Selective b-cell removal resulted in
decreased cystic structure formation, suggesting an im-
portant role for b-cells in this process. Likewise, b-cell-
depleted cultures also exhibited a relative decrease in the
frequency of nestinþ DLS cells whereas the frequency of
CKþ cells increased proportionally.
Targeted depletion of a-, d- or PP-cells was also associated
with decreased cystic structure formation, although CKþ
and nestinþ cell frequencies were unaffected, suggesting a
redundancy in the roles of these non-b-cells in CKþ DLS cell
formation in that the remaining cell types are able to com-
pensate for the absence of a single specific cell type.
To further clarify the role of individual cell types in DLS
formation, additional experiments were carried out in which
islets were infected with multiple adenoviral vectors to re-
move three endocrine cell types, theoretically leaving only
one cell type within the islet (Figure 4a). Under these con-
ditions, islets containing primarily a-, b-, d- or PP-cells
displayed reduced rates of DLS formation, coincident with
the notion that there is no one cell type that is entirely
responsible for DLS cell formation, but rather an inter-
dependence between cell types. Accordingly, removal of one
cell type affected the ability of the islet as a whole to form a
DLS.
Streptozotocin Treatment
As an alternative approach to targeted b-cell death, islets were
treated with STZ before embedding. Pre-embedding samples
were analyzed to confirm the specificity of cell death induc-
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Figure 2 GFP labeling allows in vitro cell tracking. (a) Live fluorescence microscopy of embedded islets, both initially and after 8 days in culture, confirms
that the GFP label is retained in cells and structures. (b) Fluorescence microscopy of islet-derived cells can be used to determine the fate of labeled
cell types. (c) Quantification of GFPþ cell types indicates that few cells continue to be hormoneþ , whereas many begin to express either CK or nestin
(n¼ 3-4; *Po0.05, yPo0.001 vs INS-GFP; bar¼ 100 mm).
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tion (Figure 5a). STZ treatment led to anB50% reduction in
the frequencies of b- and PP-cells, without affecting the
frequencies of a- and d-cells. Assessment of apoptotic indices
further confirmed the specificity of b- and PP-cell death
(Figure 5b).
STZ-treated islets were evaluated for DLS formation
(Figure 5c) and the frequencies of DLS cell types (Figure 5d).
Surprisingly, STZ treatment had no effect on cystic
structure formation. This result appears at odds with the
results of the Bax expression experiments (Figure 4a) that
suggested that the removal of any single endocrine
cell type impairs DLS formation. As Bax expression reduced
target cell type frequencies byB75%, whereas STZ treatment
reduced b- and PP-cell numbers by only B50%, it is
possible that a threshold exists whereby islets can withstand
limited cellular depletion without differentiation being
affected.
As for DLS cell types, the removal ofB50% of PP-cells did
not adversely affect the CKþ cell frequency, which was to be
expected given the apparent redundancy of a-, d- and PP-
cells with respect to their contribution to dedifferentiation.
STZ-mediated removal ofB50% of b-cells in islets translated
to a significant reduction in the frequency of nestinþ cells
within the DLS, confirming earlier observations of DLS
cell origin.
Table 6 DLS cell origins
Vector GFP+/CK+ (% CK+)  Efficiency1 (%) ¼ Origin (%) n
INS-GFP 0.5±0.6 35.0±3.4 1.4±4.2 4
GCG-GFP 19.1±4.1 49.8±0.8 38.4±4.1 3
SST-GFP 15.4±3.4 46.3±3.2 33.3±5.2 4
PP-GFP 15.9±2.1 43.9±1.9 36.2±2.8 3
Vector GFP+/nestin+ (% nestin+)  Efficiency1 (%) ¼ Origin (%) n
INS-GFP 26.0±0.7 35.0±3.4 74.4±0.5 4
GCG-GFP 1.6±1.1 49.8±0.8 3.3±1.1 3
SST-GFP 1.0±0.7 46.3±3.2 2.3±0.6 4
PP-GFP 2.7±1.1 43.9±1.9 6.1±1.1 3
DLS, duct-like structures.
Figure 3 Bax expression allows inverse cell tracking. (a) Quantification of islet cell frequencies, post-infection but before embedding, confirms the
specificity and efficiency of the Bax-expressing adenoviral vectors. (b) Quantification of the frequency of hormoneþ islet cells, as well as overall cell
numbers, post-infection but before embedding, confirms the specificity and efficiency of the Bax-expressing adenoviral vectors employed (n¼ 3;
*Po0.05, zPo0.01, yPo0.001 vs control, all others NS).
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Islet Redifferentiation
We have previously established that DLS can be induced to
redifferentiate into islet-like structures given the appropriate
stimulus.26 To identify the precursor-type cell(s) responsible
for islet redifferentiation in this model, we fed cultures of
DLS from STZ-treated islets with a redifferentiation medium,
with or without INGAP peptide, for 4 days (Figure 5e).
Control cultures responded to the redifferentiation medium
with a 14.2±5.3% increase in the frequency of dithizoneþ
structures, whereas INGAP peptide administration increased
this effect to 26.2±4.4%. Conversely, STZ-treated cultures
did not respond to either the redifferentiation medium alone
or in combination with INGAP peptide, indicating a defi-
ciency in redifferentiation in DLS formed from STZ-treated
cultures.
DISCUSSION
Under specific culture conditions, cultured human islets
appear to lose their endocrine phenotype and are replaced by
a heterogeneous population of seemingly primitive, highly
proliferative cells.21–26,51,55,56 Recently, investigators have
identified culture conditions under which these cells can be
induced to redifferentiate into islet-like structures, albeit with
varying degrees of endocrine phenotype and function,22–26
thereby lending support to the hypothesis that islet-derived
cells can act as precursors. Although encouraging, these
reports have been met with controversy.
Previous reports have presented evidence, including elec-
tron microscopy of individual cells with both endocrine
(endosecretory granules) and ductal (microvilli) character-
istics, and double immunofluorescence microscopy of cells
coexpressing endocrine hormones and duct cell markers,
suggesting that these precursor-type cells derive from adult
endocrine cell types.23,26,55 However, lineage tracing and
pulse–chase studies in mice have suggested that the primary
mechanism of both b-cell renewal and regeneration in the
endogenous pancreas is b-cell replication.19,20 More recently,
yet another lineage tracing study concluded that the fibro-
blast-like cells observed in mouse islet cultures do not derive
from cells of any pancreatic lineage.28 These discrepancies
between human and rodent studies led us to employ other
methods to confirm our previous double immuno-
fluorescence-based observations of an a- and d-cell origin for
the CKþ population that is observed to arise.26
In the present study, we employed a newly validated ade-
noviral coinfection technique to serve as a signal amplifier.35
In this way, we transiently labeled individual endocrine cell
types with reproducible efficiency and high specificity. Given
the strength and cumulative half-lives of the transactivator
and GFP, we were able to follow specific endocrine cell types,
even after the promoters of interest were no longer active in
the dedifferentiated cells. Thus, we observed that in our
culture system, both CKþ epithelial cells and nestinþ fi-
broblast-like cells derive from hormone-expressing endocrine
cells, albeit from different endocrine cell types.
Figure 4 Islet cell interdependence and redundancy. (a) Visual assessment of DLS formation after 8 days in culture confirms the interdependence
of islet cell types in that selective depletion of any individual cell type adversely affects DLS formation. (b) Quantification of CKþ and nestinþ islet-derived
cell frequencies indicates that a-, d- and PP-cell-derived CKþ cells increase in number to compensate for the reduced frequency of b-cell-derived
nestinþ cells in DLS derived from b-cell-depleted islets. Moreover, redundancy exists in that a-, d- and PP-cells appear to compensate for a lack of
any of these cell types so as to maintain the frequency of CKþ cells in DLS derived from a-, d- or PP-cell-depleted islets (n¼ 3; *Po0.05, zPo0.01,
yPo0.001 vs control).
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Our results suggest that the CKþ epithelial cells of DLS de-
rive primarily from glucagonþ , somatostatinþ and pancreatic
polypeptideþ cells, with approximately equal contributions
from each, while very few CKþ cells derive from insulinþ cells.
Conversely, nestinþ cells derive mainly from insulinþ cells,
while mantle cells contribute little. The possibility exists,
however, that nestinþ cells also derive from non-endocrine
cell origins, as a significant number of nestinþ cells were not
accounted for by labeled endocrine cells.
As with any promoter-based expression system, it is im-
portant to note that cell types were defined based only on the
activity of a single promoter sequence.19 Thus, a b-cell was
defined based on the presence of an active insulin promoter
at the time of culture. Accordingly, data from such studies
must be interpreted with this in mind, because sub-popula-
tions of islet cells that are insulinþ , but would not be
considered adult b-cells, have been reported previously.57 To
our knowledge, this is the first report of human promoter
sequences being used to label human islets.
With respect to lineage tracing studies, Dor et al19
acknowledged the possibility of an insulinþ precursor cell
that would be labeled as a b-cell in lineage tracing studies.
This notion is especially appealing in our in vitro islet culture
system, because we followed not only insulinþ cells, but also
the four principal endocrine cells of the islet. Our studies led
to the novel observation that there was a dichotomy with
respect to the cellular origins of the two primary cell types of
the DLS: CKþ cells derive primarily from a-, d- and PP-cells,
and nestinþ cells derive mainly from b-cells.
Targeted depletion of specific cell types by adenoviral
expression of Bax or STZ treatment was originally performed
with the intention of identifying the cell(s) responsible for
the redifferentiation potential of DLS. As such, the lack of
redifferentiation from DLS derived from STZ-treated islets
suggests an important role for b- and PP-cell-derived
cells. However, these results also serve to highlight the
interdependence of endocrine cell types with respect to DLS
formation and, presumably, islet regeneration. Thus, no cell
type can yet be proposed as an in vitro islet precursor without
true lineage tracing of the islet regeneration process. In fact, it
may well be that cells exist as facultative precursors only within
the niche defined by DLS or monolayer cultures.58 It is for this
reason that studies of redifferentiation of Bax-treated cultures
could not be carried out, for in an attempt to remove an in-
dividual cell type from the niche, the niche itself was disrupted.
Characterization of the starting tissue in these experiments
indicates a weak presence of CKþ and nestinþ cells from the
beginning, and thus the proliferation of these cells could have
possibly contributed to the resultant cell populations. How-
ever, correcting for labeling efficiencies suggests that virtually
all CKþ cells were in fact derived from endocrine cells over
the course of culture. Likewise, BrdU labeling studies carried
out previously indicated that the proliferation of CKþ cells
does not begin immediately, but only after several days in
culture, following the main wave of dedifferentiation.52,59
Finally, we do not presume to exclude a contribution of some
inherent ductal or fibroblastic cells in our preliminary cul-
tures, but rather we are reporting on the origins of cells that
seem to account for a majority of the CKþ and nestinþ cells
present at the end of the culture period. In fact, to pinpoint
the exact source of in vitro islet neogenesis, long-term lineage
tracing studies using indelible cell markers would be
required. These experiments are beyond the scope of these
studies, however, as we sought only to identify the endocrine
cell origins of cells within the DLS.
Other groups have reported on monolayers formed from
cultured islets,22–25,33 whereas our model involves three-
dimensional organotypic culture.26 Nonetheless, it seems that
the precursor-type cells we observe are very similar to those
reported in monolayer culture, especially when the culture
conditions and expression profile of both cell populations are
considered. As in the monolayer, we observe two pre-
dominant cell types: the majority of cells are CKþ and epi-
thelial in nature, whereas a less frequent nestinþ fibroblast-
like cells also exist within the DLS. Additionally, there is
heterogeneity of both Pdx1 and vimentin expression, as in
the monolayer.26
Figure 5 Streptozotocin treatment confirms inverse cell tracking.
(a) Quantification of islet cell frequencies and (b) apoptotic cell death after
STZ treatment but before embedding indicates that STZ selectively targets
b- and PP-cells. (c) STZ treatment does not affect DLS formation, as
evaluated visually after 8 days in culture. (d) The frequency of CKþ DLS cells
is unaffected by islet STZ treatment before embedding, but the frequency
of nestinþ DLS cells is reduced. (e) After culture to form DLS, switching to
redifferentiation medium (RM) allows a spontaneous reversion of DLS into
dithizoneþ islet-like structures, which is potentiated by INGAP peptide. STZ
treatment of islets before culture abrogates the redifferentiation response
of DLS, both with and without INGAP peptide (n¼ 4; *Po0.05, zPo0.01 vs
same conditions for control, zPo0.05 vs RM for control).
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At first glance, our results may appear to contradict those
reported by others who have conducted lineage tracing stu-
dies in mice.28 However, evidence is accumulating to suggest
that the non-human pancreas is not always an appropriate
model to study phenomena occurring in the human organ.60
For example, recent reports aimed at elucidating the islet
regenerative response in humans and mice indicated that
humans increase b-cell mass primarily through neogenesis,2
whereas the mouse regenerative response involves b-cell
replication.32 Likewise, cultured human islets have been
reported to form precursor cell cultures that can be induced
to redifferentiate into islet-like structures.22–26 When similar
culture conditions were applied to mouse islets, little if any
redifferentiation was observed.27,28,30,61 Taken together, these
data suggest a difference with respect to the mechanisms of
regeneration that predominate in human and non-human
tissue. Consequently, although certainly informative, the re-
sults of lineage tracing studies in mice may not necessarily be
informative of what transpires in man. In fact, a recent study
using a similar lineage tracing technique confirmed that
human, but not murine, b-cells were capable of significant
in vitro dedifferentiation and proliferation.33
Finally, a debate persists over the cellular source of
in vitro islet redifferentiation. Given the presence of
b-cells, non-b-endocrine cells and non-endocrine cells in islet
cultures, the mechanisms involved may represent b-cell
neogenesis, proliferation or both. For example, if islet-like
structures were observed to form from the CKþ epithelial
cell source, which is almost exclusively of non-b-cell origin,
this could be termed islet neogenesis. Immunofluorescence
and BrdU pulse–chase studies have provided support for this
pathway.21,26 Conversely, if b-cell-derived nestinþ cells are
observed to give rise to islet-like structures, then this could be
defined as b-cell replication, albeit indirect, given the pre-
sence of an intermediate cell type.17 Immunofluorescence
studies provide tentative support for this mechanism as
well.22 Thus, our findings do not rule out either pathway of
b-cell formation. Additional longer-term lineage tracing
studies would undoubtedly prove useful in elucidating a
predominant mechanism.
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